.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chubb
AstraZeneca
Cerilliant
Accenture
Colorcon
McKesson
Baxter
Chinese Patent Office
Healthtrust

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021248

« Back to Dashboard
NDA 021248 describes TRISENOX, which is a drug marketed by Cephalon and is included in one NDA. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TRISENOX profile page.

The generic ingredient in TRISENOX is arsenic trioxide. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the arsenic trioxide profile page.

Summary for 021248

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:6
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 021248

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRISENOX
arsenic trioxide
INJECTABLE;INJECTION 021248 NDA Cephalon, Inc. 63459-600 63459-600-10 10 AMPULE in 1 CARTON (63459-600-10) > 10 mL in 1 AMPULE (63459-600-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/ML
Approval Date:Sep 25, 2000TE:RLD:Yes
Patent:► SubscribePatent Expiration:Nov 10, 2018Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF ACUTE PROMYELOGENOUS LEUKEMIA (APL)
Patent:► SubscribePatent Expiration:Nov 10, 2018Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF ACUTE PROMYELOGENOUS LEUKEMIA (APL)
Patent:► SubscribePatent Expiration:Nov 10, 2018Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF ACUTE PROMYELOGENOUS LEUKEMIA (APL)


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Express Scripts
Dow
Chinese Patent Office
Citi
Deloitte
Julphar
Baxter
QuintilesIMS
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot